Skip to contentB
BioCardia, Inc.
B
BCDABioCardia, Inc. Q2 2014 · 10-Q
Revenue—
Net Income$66.00K$66.00K+633.3% vs Q2 2013 EPS Diluted$0.00$0.00— vs Q2 2013 Operating Income$65,000+983.3% Operating Cash Flowderived$79,000+426.7%
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCardia, Inc. · CIK 925741 · Engraved from SEC EDGAR
ended Jun 30, 2014 · filed Aug 6, 2014 · 37 d after period end